Heart failure and dementia: Survival in relation to types of heart failure and different dementia disorders

European Journal of Heart Failure

Volumn 17, Issue 6, 2015, Pages 612-619

  Cermakova, Pavla ^a,b   Lund, Lars H ^a,c   Fereshtehnejad, Seyed Mohammad ^a   Johnell, Kristina ^a   Winblad, Bengt ^a,c   Dahlström, Ulf ^d   Eriksdotter, Maria ^a,c   Religa, Dorota ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Regional Cancer Centre Southeast   (Sweden)

Author keywords

Alzheimer disease; Dementia; Heart failure; Preserved ejection fraction; Reduced ejection fraction; Registry; Survival; Vascular dementia

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE CLASSIFICATION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; SURVIVAL RATE; HEART STROKE VOLUME; MORTALITY; PHYSIOLOGY; REGISTER; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA, VASCULAR; FEMALE; HEART FAILURE; HUMANS; MALE; REGISTRIES; STROKE VOLUME; SURVIVAL RATE;

EID: 84931568707     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.222     Document Type: Article

References (27)

1. Cardiogenic Dementia,. Lancet 1977; 1: 27-28.
2. Solomon A, Mangialasche F, Richard E, Andrieu S, Bennett DA, Breteler M, Fratiglioni L, Hooshmand B, Khachaturian AS, Schneider LS, Skoog I, Kivipelto M,. Advances in the prevention of Alzheimer's disease and dementia. J Intern Med 2014; 275: 229-250.
3. Angermann CE, Frey A, Ertl G,. Cognition matters in cardiovascular disease and heart failure. Eur Heart J 2012; 33: 1721-1723.
4. Garcia-Ptacek S, Faxen-Irving G, Cermakova P, Eriksdotter M, Religa D,. Body mass index in dementia. Eur J Clin Nutr 2014; 68: 1204-1209.
5. Cermakova P, Eriksdotter M, Lund LH, Winblad B, Religa P, Religa D,. Heart failure and Alzheimer's disease. J Intern Med 2014; doi: 10.1111/joim.12287, in press.
6. Roher AE,. Cardiovascular system participation in Alzheimer's disease pathogenesis. J Intern Med 2014; doi: 10.1111/joim.12311, in press.
7. Lam CS, Solomon SD,. The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%). Eur J Heart Fail 2014; 16: 1049-1055.
8. Meta-analysis Global Group in Chronic Heart Failure. The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 2012; 33: 1750-1757.
9. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM,. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
10. Poppe KK, Squire IB, Whalley GA, Kober L, McAlister FA, McMurray JJ, Pocock S, Earle NJ, Berry C, Doughty RN,. Meta-Analysis Global Group in Chronic Heart F. Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report. Eur J Heart Fail 2013; 15: 1220-1227.
11. Campbell RT, Jhund PS, Castagno D, Hawkins NM, Petrie MC, McMurray JJ,. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? J Am Coll Cardiol 2012; 60: 2349-2356.
12. Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC,. Get With the Guidelines Scientific Advisory Council Investigators. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation 2012; 126: 65-75.
13. Sachdev P, Kalaria R, O'Brien J, Skoog I, Alladi S, Black SE, Blacker D, Blazer DG, Chen C, Chui H, Ganguli M, Jellinger K, Jeste DV, Pasquier F, Paulsen J, Prins N, Rockwood K, Roman G, Scheltens P,. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord 2014; 28: 206-218.
14. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, Lobo A, Martinez-Lage J, Soininen H, Hofman A,. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54 (Suppl 5): S10-S15.
15. Rockwood K, Macknight C, Wentzel C, Black S, Bouchard R, Gauthier S, Feldman H, Hogan D, Kertesz A, Montgomery P,. The diagnosis of 'mixed' dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC). Ann N Y Acad Sci 2000; 903: 522-528.
16. Garcia-Ptacek S, Farahmand B, Kareholt I, Religa D, Cuadrado ML, Eriksdotter M,. Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry. J Alzheimers Dis 2014; 41: 467-477.
17. Jonsson A, Edner M, Alehagen U, Dahlstrom U,. Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur J Heart Fail 2010; 12: 25-31.
18. Religa D, Spångberg K, Wimo A, Edlund AK, Winblad B, Eriksdotter-Jönhagen M,. Dementia Diagnosis Differs in Men and Women and Depends on Age and Dementia Severity: Data from SveDem, the Swedish Dementia Quality Registry. Dement Geriatr Cogn Disord 2012; 33: 90-95.
19. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva: WHO; 1993.
20. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ,. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001; 154: 854-864.
21. Lund LH, Jurga J, Edner M, Benson L, Dahlstrom U, Linde C, Alehagen U,. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. Eur Heart J 2013; 34: 529-539.
22. Cermakova P, Fereshtehnejad SM, Johnell K, Winblad B, Eriksdotter M, Religa D,. Cardiovascular medication burden in dementia disorders: a nationwide study of 19,743 dementia patients in the Swedish Dementia Registry. Alzheimers Res Ther 2014; 6: 34.
23. Holmstrom A, Sigurjonsdottir R, Edner M, Jonsson A, Dahlstrom U, Fu ML,. Increased comorbidities in heart failure patients≥85years but declined from >90years: data from the Swedish Heart Failure Registry. Int J Cardiol 2013; 167: 2747-2752.
24. Hjelm C, Brostrom A, Dahl A, Johansson B, Fredrikson M, Stromberg A,. Factors associated with increased risk for dementia in individuals age 80years or older with congestive heart failure. J Cardiovasc Nurs 2014; 29: 82-90.
25. Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L,. Heart failure and risk of dementia and Alzheimer disease: a population-based cohort study. Arch Intern Med 2006; 166: 1003-1008.
26. Fitzpatrick AL, Kuller LH, Lopez OL, Kawas CH, Jagust W,. Survival following dementia onset: Alzheimer's disease and vascular dementia. J Neurol Sci 2005; 229-230: 43-49.
27. Knopman DS, Rocca WA, Cha RH, Edland SD, Kokmen E,. Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol 2003; 60: 85-90.